Mark Cuban dropped a bomb on healthcare AI optimists this week. Responding to Marc Andreessen's claim that "AI is already a better doctor than 99.99% of human doctors," Cuban argued the opposite: AI won't fix healthcare because insurers will weaponize the same technology to deny care even faster.
"For every future agent we give AI doctors to deal with this friction, and to improve the quality of care, the conglomerates will have multiple adversarial agents doing all they can to delay and deny, to minimize their cost and maximize their float."
He called it "the agentic version of Mad magazine's Spy vs. Spy" — an endless escalation where AI fights AI and patients lose.
Cuban is half right. Payer-side AI is absolutely being used to accelerate denials. But he's dead wrong about the conclusion. Provider-side AI that prevents denials before claims are submitted doesn't fight the arms race — it makes it irrelevant.
The 25% Tax: Why Cuban's Diagnosis Is Correct
Cuban's core observation is accurate: at least 25% of a physician's time is consumed by administrative friction created by insurers, pharmacy benefit managers, and other healthcare intermediaries. That friction isn't accidental — it's profitable for the intermediaries.
The numbers support him. The AMA reports physicians spend 13 hours per week on prior authorization alone. Health benefit costs per employee have climbed above $18,500 in 2026 — the steepest annual jump in fifteen years (Mercer). Initial denial rates have reached 11.65% (HFMA/CombineHealth). And Cuban correctly identifies that hospitals pay revenue cycle management companies up to 10% of revenue just to fight back against the denial machine.
"We see this already as the conglomerates use AI to find every possible way to manipulate contracts, and find ways to mislead," Cuban wrote on X. He's describing a real dynamic — payers are deploying AI to identify denial opportunities at scale, while providers scramble to respond with their own AI defenses.
Where Cuban Goes Wrong: The "Spy vs. Spy" Fallacy
Cuban's mistake is assuming provider-side AI plays the same game as payer-side AI. It doesn't.
Payer AI is fundamentally adversarial: it looks for reasons to deny claims after submission, identifies contractual loopholes, and automates rejection workflows. Provider-side AI is fundamentally preventive: it validates eligibility before the patient visit, ensures coding accuracy before submission, and completes prior authorization documentation before filing.
These aren't two sides of the same arms race. They operate on entirely different timelines.
| Dimension | Payer-Side AI | Provider-Side AI |
|---|---|---|
| Timing | Post-submission (reactive) | Pre-submission (preventive) |
| Goal | Find reasons to deny | Eliminate reasons for denial |
| Data Advantage | Contract terms, historical patterns | Clinical documentation, eligibility, coding |
| Patient Impact | Delays care, increases burden | Accelerates access, reduces surprise bills |
| ROI Model | Savings from denied claims | Revenue from clean claims |
When provider-side AI validates insurance eligibility in real time, catches coding errors before submission, and ensures prior authorization documentation is complete before filing, there's nothing for payer AI to deny. You don't need to outfight the adversarial agents if you've already eliminated the attack surface.
The Prevention Numbers Cuban Missed
Former HCA CFO Bill Rutherford — now on Ensemble Health Partners' Board of Managers — articulated the prevention-first approach in a MobiHealthNews interview this week: AI can "reduce the need for manual chart reviews and identify possible claim delays and denials before they occur" to help health systems prevent revenue leakage and improve cash flow.
Rutherford told Healthcare IT News that healthcare leaders must "deploy technology broadly to achieve meaningful returns" — not patch individual problems but transform the entire revenue cycle workflow.
The data backs him up:
- Clean claim rates: 84-88% → 94-98% with AI pre-submission validation (Zedtreeo 2026)
- Denial rate reduction: 30-50% with AI-powered prevention (ResearchIntelo/Advalorem 2026)
- Days in AR: 15-25 days faster resolution with AI automation
- Average ROI: 451% (5-8x return) on AI RCM investment
- Cost to collect: 15-30% lower with end-to-end AI automation
When clean claims hit 94-98%, there's almost nothing left for payer AI to attack. That's not Spy vs. Spy — it's making the war pointless by denying the adversary targets.
Cuban's Best Insight: "Run Every Contract Through Claude"
Ironically, Cuban's most actionable healthcare AI advice perfectly supports the provider-side AI thesis. In a "Digital Health Heavyweights" podcast episode that aired Monday, Cuban told employers:
"Run them all. Every healthcare contract you have run through Claude or whatever, and just say, 'Where am I getting ripped off?'"
He's right. Healthcare contracts — often hundreds of pages — contain buried clauses that systematically disadvantage providers: aggressive timely filing limits, bundling rules that trigger downgrades, and reimbursement terms pegged to percentages of Medicare that haven't been updated in years.
This is exactly what AI-powered fee schedule analysis does for medical practices:
- Contract rate comparison — AI compares every payer's reimbursement rates against Medicare benchmarks and identifies procedures being paid below market
- Clause extraction — AI surfaces buried terms that cost practices revenue: timely filing deadlines, modifier requirements, bundling rules, and escalation pathways
- Underpayment pattern detection — AI analyzes historical claims data to identify systematic underpayment by specific payers across specific CPT codes
Cuban's contract transparency play isn't the opposite of provider-side AI — it's a core component of it. The same AI infrastructure that prevents denials at submission also identifies where contracts are leaving money on the table after payment.
The AJMC Closing: Why Data Standardization Changes Everything
AJMC published a commentary this month titled "AI in Health Care: Closing the Revenue Cycle Gap" that frames the path forward: collaboration, data standardization, and targeted implementation are what determine whether AI actually delivers results or creates the Spy vs. Spy stalemate Cuban fears.
The CAQH Index — healthcare's authoritative administrative benchmark — already quantified the prize: $20 billion in cost savings from broader automation adoption. That includes $10 billion from eligibility verification alone. But the savings require more than throwing AI at the problem. They require:
- Clean data foundations — AI running on dirty, unstandardized data produces garbage outputs that payer AI will catch and exploit
- Targeted workflows — deploying AI where the highest-value administrative transactions happen (eligibility, PA, coding) rather than everywhere at once
- Provider-specific tuning — generic AI models fail at healthcare RCM because every payer, every contract, and every specialty has different rules. Institution-tuned models — what AKASA CEO Malinka Walaliyadde calls AI trained on patient records that "average 60 documents and 50,000 words" — deliver accuracy that generic approaches cannot match
The Real Equation: Why Provider AI Isn't an Arms Race
Cuban's Spy vs. Spy metaphor only holds if both sides are playing the same game. They aren't.
Payer AI operates on a zero-sum model: every dollar denied is a dollar saved. Provider AI operates on a positive-sum model: every denial prevented is revenue captured, patient friction eliminated, and administrative cost reduced simultaneously. When a practice's AI catches an eligibility gap before the patient arrives, it's not fighting the insurer — it's making the right thing happen upstream so the fight never starts.
The practices winning this moment aren't the ones deploying bigger denial-fighting armies. They're the ones deploying AI that makes the entire denial cycle irrelevant:
- Real-time eligibility verification — catches coverage gaps, inactive policies, and secondary insurance before the visit
- Automated prior authorization — submits complete clinical documentation with the request, eliminating the #1 denial reason (missing information)
- Pre-submission claim validation — checks coding accuracy, modifier requirements, and medical necessity documentation against payer-specific rules before the claim is submitted
- Intelligent denial management — when denials do occur, AI generates appeals with the exact clinical evidence the payer's own rules require for overturn
- Fee schedule analysis — continuously monitors payer contracts for underpayment patterns and flags renegotiation opportunities
This isn't deploying "adversarial agents" against insurer AI. It's building infrastructure that makes adversarial friction unprofitable for payers to pursue.
What This Means for Your Practice
Cuban's warning has real urgency — just not the conclusion he draws. The practices that wait to see how the "arms race" plays out will spend the next two years watching their denial rates climb, their AR days extend, and their staff drown in administrative overhead.
The practices that act now will deploy AI that:
- Prevents 30-50% of denials before they happen
- Achieves 94-98% clean claim rates on first submission
- Reduces AR days by 15-25 days
- Exposes hidden contract costs Cuban correctly identifies
- Returns $4.50+ for every $1 invested
Mark Cuban is right that the healthcare system is broken and intermediaries have every incentive to weaponize AI. He's wrong that provider-side AI is just the other half of an endless arms race. Prevention isn't the same game as denial. And the data proves it.